Paul M Dunman

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 6

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 1.9

ph-index = 1

Forward Citations = 2(Granted Patents)

Company Filing History:

10 out of 975

University of Rochester

University of Nebraska

where one patent can have more than one assignee

Years Active: 2015-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11096923 - Pharmaceutical composition containing polymyxin B/trimethoprim based therapeutics (2021-08-24),

2. 11065274 - Prevention and treatment for microbial infections (2021-07-20),

3. 10525032 - Antimicrobial compositions comprising mupirocin and neomycin (2020-01-07),

4. 10471028 - Small molecule efflux pump inhibitors (2019-11-12),

5. 10028931 - Synergistic compositions for treating microbial infections (2018-07-24),

6. 10004701 - Methods and compositions for treating infection (2018-06-26),

7. 9693999 - Small molecule RNase inhibitors and methods of use (2017-07-04),

8. 9517230 - Small molecule RNase inhibitors and methods of use (2016-12-13),

9. 9233095 - Small molecule RNase inhibitors and methods of use (2016-01-12),

10. 9089545 - Small molecule RNase inhibitors and methods of use (2015-07-28),

Sure, I can help you with that. Let's get started on the article about inventor Paul M. Dunman.

Title: The Inventor Paul M. Dunman: A Pioneer in Pharmaceutical Innovations

Introduction:

Paul M. Dunman, a renowned inventor based in Pittsford, NY (US), has made significant contributions to the field of pharmaceutical compositions and microbial infection treatments. With a total of 10 patents to his name, Dunman continues to push the boundaries of medical science.

Latest Patents:

Dunman's latest patents showcase his ingenuity in the field of antibacterial compositions and treatments for microbial infections. One of his recent inventions includes a pharmaceutical composition containing polymyxin B and trimethoprim, coupled with an antibiotic agent to effectively treat bacterial infections. Another groundbreaking patent features a composition comprising zinc pyrithione and silver sulfadiazine, offering new avenues for preventing and treating microbial infections.

Career Highlights:

Throughout his illustrious career, Dunman has been associated with esteemed institutions such as the University of Rochester and Temple University—of the Commonwealth System of Higher Education. His work and dedication to innovation have proven instrumental in advancing the field of pharmaceuticals and medical treatments.

Collaborations:

Dunman's collaborations with notable individuals like Wayne Everett Childers and Patrick D. Olson have further propelled his research and inventions to new heights. Together, they have explored innovative solutions to combat microbial infections and improve patient outcomes.

Conclusion:

In conclusion, Paul M. Dunman stands as a trailblazer in the realm of pharmaceutical innovations, with a substantial patent portfolio and a legacy of groundbreaking inventions. His relentless pursuit of excellence and commitment to improving healthcare make him a standout figure in the world of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.